Opportunities, Challenges and Unanswered Questions Unveiled from Center for Supply Chain Studies Industry Research Team
Original webcast: January 9, 2018
Blockchain, a distributed ledger technology where “blocks” containing a secured growing list of ordered records are created and maintained in an open network, has the potential to play an important part in the pharmaceutical supply chain’s implementation of interoperable electronic tracing of medicines to meet DSCSA 2023 regulations.
Join Robert Celeste, Founder of the Center for Supply Chain Studies (CSCS), for a special 60-minute discussion of blockchain, its potential roles for DSCSA 2023, and the potential benefits and challenges for adoption of this technology gained by the CSCS DSCSA & Blockchain study team made up of over 50 key industry leaders from every segment of the supply chain.
In this on-demand webinar replay, you will learn:
Core fundamentals of blockchain and how they relate to DSCSA regulatory and business requirements.
Key challenges and points of investigation in the use of blockchain from establishing electronic connections and trust between trading partners to storing, protecting and sharing compliance and operational data in systems which may be within the blockchain and may reside outside of a blockchain.
The different models being considered for how blockchain nodes, supply chain services, compliance systems and business entities across the supply chain maybe be connected and interoperate.
Initial insights and open questions that the industry needs to understand in creating an interoperable path forward potentially incorporating blockchain technology.